Sanofi (SNY) Divestments (2024 - 2025)
Sanofi (SNY) posted Divestments of -$41.9 million for Q4 2025, little changed sequentially from -$42.1 million in Q3 2025, and up 64.02% YoY from -$25.5 million in Q4 2024.
Sanofi (SNY) Divestments (2024 - 2025) Analysis & Trends
Sanofi (SNY) has 2 years of Divestments data on file, last reported at -$41.9 million in Q4 2025.
- Quarterly Divestments rose 64.02% year-over-year to -$41.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$692.3 million (changed N/A YoY) and the FY2023 annual result came in at $45.4 million, up 2.63% from the prior year.
- Divestments held at -$41.9 million in Q4 2025 per SNY's latest filing, from -$42.1 million in the prior quarter.
- The five-year high for Divestments was -$9.5 million in Q1 2025, with the low at -$2.0 billion in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | - |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | - |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | - |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | - |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | - |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | -2.00 Mn |
| 10 | Sanofi | - | - | 9.49 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -41.91 Mn |
| Sep 30, 2025 | -42.09 Mn |
| Jun 30, 2025 | -598.81 Mn |
| Mar 31, 2025 | -9.47 Mn |
| Dec 31, 2024 | -116.48 Mn |
| Jun 30, 2024 | -2.02 Bn |
| Mar 31, 2024 | -9.78 Mn |